Interaction of Masitinib with Organic Cation Transporters

Tyrosine kinase inhibitors (TKI) such as Masitinib were reported to be useful as therapeutic options in malignant disorders and nonmalignant diseases, like coronavirus disease 2019 (COVID-19). Most kinases must be translocated into targeted cells by the action of specific transport proteins, as they...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrach, Saliha, Haag, Jasmin, Steinbüchel, Martin, Schröter, Rita, Neugebauer, Ute, Bertrand, Jessica, Ciarimboli, Giuliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693006/
https://www.ncbi.nlm.nih.gov/pubmed/36430667
http://dx.doi.org/10.3390/ijms232214189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693006/
https://www.ncbi.nlm.nih.gov/pubmed/36430667
http://dx.doi.org/10.3390/ijms232214189

Ejemplares similares